SCHEMBL20005178

SCHEMBL20005178

Fc1ccc(Cc2cc3cccnc3[nH]2)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 4/20 0.47
WDR77 Q9BQA1 4/20 0.47
RIPK1 Q13546 3/20 0.47
MAPK14 Q16539 1/20 0.46
DAO P14920 1/20 0.45
DRD2 P14416 2/20 0.44
DRD4 P21917 2/20 0.44
DRD3 P35462 2/20 0.44
NR3C1 P04150 1/20 0.43
NR3C2 P08235 1/20 0.43
CCNE1 P24864 1/20 0.43
CDK2 P24941 1/20 0.43
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2113619 0.86 DRD2 (0.53) RIPK1MAPK14DAODRD2DRD4
SCHEMBL1362779 0.77 RIPK1 (0.55) RIPK1DAODRD2DRD4DRD3
SCHEMBL6994522 0.74 LOXL2 (0.53) DRD2DRD4DRD3
SCHEMBL857198 0.74 GLRA3 (0.50) PRMT5WDR77MEN1KMT2A
SCHEMBL4518152 0.74 HDAC1 (0.49) PRMT5WDR77NR3C1NR3C2CDK2
SCHEMBL25230913 0.74 DRD2 (0.50) RIPK1DAODRD2DRD4DRD3
SCHEMBL2176426 0.74 LOXL2 (0.52) RIPK1DAODRD2DRD4DRD3
SCHEMBL1939638 0.74 DRD2 (0.50) RIPK1DAODRD2DRD4DRD3
SCHEMBL13543890 0.74 RIPK1 (0.58) RIPK1DAODRD2DRD4DRD3
SCHEMBL17451039 0.74 DRD2 (0.50) RIPK1DAODRD2DRD4DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3515912-B1 COMPOUNDS FOR USING IN IMAGING AND PARTICULARLY FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISEASES CENTRE NAT RECH SCIENT (FR) 2020-10-14 EP disclosed
WO-2018055316-A1 COMPOUNDS FOR USING IN IMAGING AND PARTICULARLY FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISEASES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2018-03-29 WO disclosed